Choices of Stent and Cerebral Protection in the Ongoing ACST-2 Trial

A Descriptive Study

D. D. de Waard, A. Halliday, G. J. de Borst, R. Bulbulia, A. Huibers, R. Casana, L. H. Bonati, V. Tolva, ACST-2 Collaborative Group

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Objective/Background Several plaque and lesion characteristics have been associated with an increased risk for procedural stroke during or shortly after carotid artery stenting (CAS). While technical advancements in stent design and cerebral protection devices (CPD) may help reduce the procedural stroke risk, and anatomy remains important, tailoring stenting procedures according to plaque and lesion characteristics might be a useful strategy in reducing stroke associated with CAS. In this descriptive report of the ongoing Asymptomatic Carotid Surgery Trial-2 (ACST-2), it was assessed whether choice for stent and use or type of CPD was influenced by plaque and lesion characteristics. Methods Trial patients who underwent CAS between 2008 and 2015 were included in this study. Chi-square statistics were used to study the effects of plaque echolucency, ipsilateral preocclusive disease (90–99%), and contralateral high-grade stenosis (>50%) or occlusion of the carotid artery on interventionalists’ choice for stent and CPD. Differences in treatment preference between specialties were also analysed. Results In this study, 831 patients from 88 ACST-2 centres were included. Almost all procedures were performed by either interventional radiologists (50%) or vascular surgeons (45%). Plaque echolucency, ipsilateral preocclusive disease (90–99%), and significant contralateral stenosis (>50%) or occlusion did not affect the choice of stent or either the use of cerebral protection and type of CPD employed (i.e., filter/flow reversal). Vascular surgeons used a CPD significantly more often than interventional radiologists (98.6% vs. 76.3%; p < .001), but this choice did not appear to be dependent on patient characteristics. Conclusion In ACST-2, plaque characteristics and severity of stenosis did not primarily determine interventionalists’ choice of stent or use or type of CPD, suggesting that other factors, such as vascular anatomy or personal and centre preference, may be more important. Stent and CPD use was highly heterogeneous among participating European centres.

Original languageEnglish
Pages (from-to)617-625
Number of pages9
JournalEuropean Journal of Vascular and Endovascular Surgery
Volume53
Issue number5
DOIs
Publication statusPublished - May 1 2017

Fingerprint

Stents
Equipment and Supplies
Carotid Arteries
Blood Vessels
Pathologic Constriction
Stroke
Anatomy

Keywords

  • Carotid artery stenosis
  • Carotid artery stenting
  • Cerebral protection devices
  • Plaque echolucency
  • Randomized controlled trial
  • Stent design

ASJC Scopus subject areas

  • Surgery
  • Cardiology and Cardiovascular Medicine

Cite this

de Waard, D. D., Halliday, A., de Borst, G. J., Bulbulia, R., Huibers, A., Casana, R., ... ACST-2 Collaborative Group (2017). Choices of Stent and Cerebral Protection in the Ongoing ACST-2 Trial: A Descriptive Study. European Journal of Vascular and Endovascular Surgery, 53(5), 617-625. https://doi.org/10.1016/j.ejvs.2016.12.034

Choices of Stent and Cerebral Protection in the Ongoing ACST-2 Trial : A Descriptive Study. / de Waard, D. D.; Halliday, A.; de Borst, G. J.; Bulbulia, R.; Huibers, A.; Casana, R.; Bonati, L. H.; Tolva, V.; ACST-2 Collaborative Group.

In: European Journal of Vascular and Endovascular Surgery, Vol. 53, No. 5, 01.05.2017, p. 617-625.

Research output: Contribution to journalArticle

de Waard, DD, Halliday, A, de Borst, GJ, Bulbulia, R, Huibers, A, Casana, R, Bonati, LH, Tolva, V & ACST-2 Collaborative Group 2017, 'Choices of Stent and Cerebral Protection in the Ongoing ACST-2 Trial: A Descriptive Study', European Journal of Vascular and Endovascular Surgery, vol. 53, no. 5, pp. 617-625. https://doi.org/10.1016/j.ejvs.2016.12.034
de Waard, D. D. ; Halliday, A. ; de Borst, G. J. ; Bulbulia, R. ; Huibers, A. ; Casana, R. ; Bonati, L. H. ; Tolva, V. ; ACST-2 Collaborative Group. / Choices of Stent and Cerebral Protection in the Ongoing ACST-2 Trial : A Descriptive Study. In: European Journal of Vascular and Endovascular Surgery. 2017 ; Vol. 53, No. 5. pp. 617-625.
@article{6d34e488a7f84b5fa76a717000fed329,
title = "Choices of Stent and Cerebral Protection in the Ongoing ACST-2 Trial: A Descriptive Study",
abstract = "Objective/Background Several plaque and lesion characteristics have been associated with an increased risk for procedural stroke during or shortly after carotid artery stenting (CAS). While technical advancements in stent design and cerebral protection devices (CPD) may help reduce the procedural stroke risk, and anatomy remains important, tailoring stenting procedures according to plaque and lesion characteristics might be a useful strategy in reducing stroke associated with CAS. In this descriptive report of the ongoing Asymptomatic Carotid Surgery Trial-2 (ACST-2), it was assessed whether choice for stent and use or type of CPD was influenced by plaque and lesion characteristics. Methods Trial patients who underwent CAS between 2008 and 2015 were included in this study. Chi-square statistics were used to study the effects of plaque echolucency, ipsilateral preocclusive disease (90–99{\%}), and contralateral high-grade stenosis (>50{\%}) or occlusion of the carotid artery on interventionalists’ choice for stent and CPD. Differences in treatment preference between specialties were also analysed. Results In this study, 831 patients from 88 ACST-2 centres were included. Almost all procedures were performed by either interventional radiologists (50{\%}) or vascular surgeons (45{\%}). Plaque echolucency, ipsilateral preocclusive disease (90–99{\%}), and significant contralateral stenosis (>50{\%}) or occlusion did not affect the choice of stent or either the use of cerebral protection and type of CPD employed (i.e., filter/flow reversal). Vascular surgeons used a CPD significantly more often than interventional radiologists (98.6{\%} vs. 76.3{\%}; p < .001), but this choice did not appear to be dependent on patient characteristics. Conclusion In ACST-2, plaque characteristics and severity of stenosis did not primarily determine interventionalists’ choice of stent or use or type of CPD, suggesting that other factors, such as vascular anatomy or personal and centre preference, may be more important. Stent and CPD use was highly heterogeneous among participating European centres.",
keywords = "Carotid artery stenosis, Carotid artery stenting, Cerebral protection devices, Plaque echolucency, Randomized controlled trial, Stent design",
author = "{de Waard}, {D. D.} and A. Halliday and {de Borst}, {G. J.} and R. Bulbulia and A. Huibers and R. Casana and Bonati, {L. H.} and V. Tolva and {ACST-2 Collaborative Group}",
year = "2017",
month = "5",
day = "1",
doi = "10.1016/j.ejvs.2016.12.034",
language = "English",
volume = "53",
pages = "617--625",
journal = "European Journal of Vascular and Endovascular Surgery",
issn = "1078-5884",
publisher = "W.B. Saunders Ltd",
number = "5",

}

TY - JOUR

T1 - Choices of Stent and Cerebral Protection in the Ongoing ACST-2 Trial

T2 - A Descriptive Study

AU - de Waard, D. D.

AU - Halliday, A.

AU - de Borst, G. J.

AU - Bulbulia, R.

AU - Huibers, A.

AU - Casana, R.

AU - Bonati, L. H.

AU - Tolva, V.

AU - ACST-2 Collaborative Group

PY - 2017/5/1

Y1 - 2017/5/1

N2 - Objective/Background Several plaque and lesion characteristics have been associated with an increased risk for procedural stroke during or shortly after carotid artery stenting (CAS). While technical advancements in stent design and cerebral protection devices (CPD) may help reduce the procedural stroke risk, and anatomy remains important, tailoring stenting procedures according to plaque and lesion characteristics might be a useful strategy in reducing stroke associated with CAS. In this descriptive report of the ongoing Asymptomatic Carotid Surgery Trial-2 (ACST-2), it was assessed whether choice for stent and use or type of CPD was influenced by plaque and lesion characteristics. Methods Trial patients who underwent CAS between 2008 and 2015 were included in this study. Chi-square statistics were used to study the effects of plaque echolucency, ipsilateral preocclusive disease (90–99%), and contralateral high-grade stenosis (>50%) or occlusion of the carotid artery on interventionalists’ choice for stent and CPD. Differences in treatment preference between specialties were also analysed. Results In this study, 831 patients from 88 ACST-2 centres were included. Almost all procedures were performed by either interventional radiologists (50%) or vascular surgeons (45%). Plaque echolucency, ipsilateral preocclusive disease (90–99%), and significant contralateral stenosis (>50%) or occlusion did not affect the choice of stent or either the use of cerebral protection and type of CPD employed (i.e., filter/flow reversal). Vascular surgeons used a CPD significantly more often than interventional radiologists (98.6% vs. 76.3%; p < .001), but this choice did not appear to be dependent on patient characteristics. Conclusion In ACST-2, plaque characteristics and severity of stenosis did not primarily determine interventionalists’ choice of stent or use or type of CPD, suggesting that other factors, such as vascular anatomy or personal and centre preference, may be more important. Stent and CPD use was highly heterogeneous among participating European centres.

AB - Objective/Background Several plaque and lesion characteristics have been associated with an increased risk for procedural stroke during or shortly after carotid artery stenting (CAS). While technical advancements in stent design and cerebral protection devices (CPD) may help reduce the procedural stroke risk, and anatomy remains important, tailoring stenting procedures according to plaque and lesion characteristics might be a useful strategy in reducing stroke associated with CAS. In this descriptive report of the ongoing Asymptomatic Carotid Surgery Trial-2 (ACST-2), it was assessed whether choice for stent and use or type of CPD was influenced by plaque and lesion characteristics. Methods Trial patients who underwent CAS between 2008 and 2015 were included in this study. Chi-square statistics were used to study the effects of plaque echolucency, ipsilateral preocclusive disease (90–99%), and contralateral high-grade stenosis (>50%) or occlusion of the carotid artery on interventionalists’ choice for stent and CPD. Differences in treatment preference between specialties were also analysed. Results In this study, 831 patients from 88 ACST-2 centres were included. Almost all procedures were performed by either interventional radiologists (50%) or vascular surgeons (45%). Plaque echolucency, ipsilateral preocclusive disease (90–99%), and significant contralateral stenosis (>50%) or occlusion did not affect the choice of stent or either the use of cerebral protection and type of CPD employed (i.e., filter/flow reversal). Vascular surgeons used a CPD significantly more often than interventional radiologists (98.6% vs. 76.3%; p < .001), but this choice did not appear to be dependent on patient characteristics. Conclusion In ACST-2, plaque characteristics and severity of stenosis did not primarily determine interventionalists’ choice of stent or use or type of CPD, suggesting that other factors, such as vascular anatomy or personal and centre preference, may be more important. Stent and CPD use was highly heterogeneous among participating European centres.

KW - Carotid artery stenosis

KW - Carotid artery stenting

KW - Cerebral protection devices

KW - Plaque echolucency

KW - Randomized controlled trial

KW - Stent design

UR - http://www.scopus.com/inward/record.url?scp=85014838339&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014838339&partnerID=8YFLogxK

U2 - 10.1016/j.ejvs.2016.12.034

DO - 10.1016/j.ejvs.2016.12.034

M3 - Article

VL - 53

SP - 617

EP - 625

JO - European Journal of Vascular and Endovascular Surgery

JF - European Journal of Vascular and Endovascular Surgery

SN - 1078-5884

IS - 5

ER -